Antithrombotic mechanism of action of BAY 59–7939 – a novel, oral, direct Factor Xa inhibitorPoster presentation at the International Society on Thrombosis and Haemostasis XXth Congress, Sydney, Australia, 6–12 August - Fareed, J; Hoppensteadt, D; Maddenini, J (2005)
P0518.